v3.25.3
Debt, Cash and Cash Equivalents - Summary of Reconciliation of Carrying Amount to Value on Redemption (Details) - EUR (€)
€ in Millions
Jun. 30, 2025
Dec. 31, 2024
Jun. 30, 2024
 [2]
Dec. 31, 2023
 [2]
Disclosure of reconciliation of carrying amount to value on redemption [line items]        
Long-term debt [1] € 13,200 € 11,791    
Short-term debt and current portion of long-term debt [1] 7,309 4,209    
Interest rate and currency derivatives used to manage debt 10 137    
Total debt 20,519 16,137    
Cash and cash equivalents [1] (15,359) (7,441) € (6,795) € (8,710)
Interest rate and currency derivatives used to manage cash and cash equivalents (58) 76    
Net debt [3] 5,102 8,772    
Lease liabilities 1,776 1,906    
Amortized cost        
Disclosure of reconciliation of carrying amount to value on redemption [line items]        
Long-term debt 39      
Short-term debt and current portion of long-term debt 2      
Interest rate and currency derivatives used to manage debt 0      
Total debt 41      
Cash and cash equivalents 0      
Interest rate and currency derivatives used to manage cash and cash equivalents 0      
Net debt [3] 41      
Adjustment to debt measured at fair value        
Disclosure of reconciliation of carrying amount to value on redemption [line items]        
Long-term debt 78      
Short-term debt and current portion of long-term debt 0      
Interest rate and currency derivatives used to manage debt (78)      
Total debt 0      
Cash and cash equivalents 0      
Interest rate and currency derivatives used to manage cash and cash equivalents 0      
Net debt [3] 0      
Value on redemption        
Disclosure of reconciliation of carrying amount to value on redemption [line items]        
Long-term debt 13,317 11,940    
Short-term debt and current portion of long-term debt 7,311 4,218    
Interest rate and currency derivatives used to manage debt (68) 13    
Total debt 20,560 16,171    
Cash and cash equivalents (15,359) (7,441)    
Interest rate and currency derivatives used to manage cash and cash equivalents (58) 76    
Net debt [3] € 5,143 € 8,806    
[1] These unaudited condensed half year consolidated financial statements as of June 30, 2025 should be read in conjunction with Sanofi’s audited consolidated financial statements as of December 31, 2024.
[2] Figures for the 2024 comparative period have been re-presented on a consistent basis to reflect the classification of Opella as a discontinued operation.
[3] Net debt does not include lease liabilities, which amounted to €1,776 million as of June 30, 2025 and €1,906 million as of December 31, 2024.